Approval · Notice of Compliance 21932 · 2019
FUZEON: Notice of Compliance 21932
Issued March 6, 2019
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 21932
- Date
- March 6, 2019
- Company
- Hoffmann-La Roche LimitedMississauga, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Labelling Only
- Reason
- Updates to inner and outer labels abd package insert to be in compliance with plain language labelling requirements
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| FUZEON | Not yet assigned | — |
Medicinal ingredients
- ENFUVIRTIDE 108 MG per VIAL